The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Antisense targeting of basic fibroblast growth factor and dibroblast growth factor receptor-1 in human melanomas blocks intratumoral angiogenesis and tumor growth
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885
A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma
van der Bruggen, P., Traversari, C., Chomez, P., Lurquin, C., De Plaen, E., Van den Eynde, B., Knuth, A., & Boon, T. (1991) · Science · doi:10.1126/science.1840703 · Cited by 3,545
Requirement of Vascular Integrin α v β 3 for Angiogenesis
Brooks, P. C., Clark, R. A. F., & Cheresh, D. A. (1994) · Science · doi:10.1126/science.7512751 · Cited by 3,020
Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels
Brooks, P. C., Montgomery, A. M. P., Rosenfeld, M., Reisfeld, R. A., Hu, T., Klier, G., & Cheresh, D. A. (1994) · Cell · doi:10.1016/0092-8674(94)90007-8 · Cited by 2,262
Xenogeneic Monoclonal Antibodies to Mouse Lymphoid Differentiation Antigens*
Ledbetter, J. A., & HERZENBERG, L. A. (1979) · Immunological Reviews · doi:10.1111/j.1600-065x.1979.tb00289.x · Cited by 1,914
Nabel, G. J., Nabel, E. G., Yang, Z. Y., Fox, B. A., Plautz, G. E., Gao, X., Huang, L., Shu, S., Gordon, D., & Chang, A. E. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.23.11307 · Cited by 882
A novel cationic liposome reagent for efficient transfection of mammalian cells
Gao, X., & Huang, L. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(91)91366-k · Cited by 847
The vascular endothelial growth factor family of polypeptides
Ferrara, N., Houck, K. A., Jakeman, L. B., Winer, J., & Leung, D. W. (1991) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240470305 · Cited by 641
Dionne, C. A., Crumley, G., Bellot, F., Kaplow, J. M., Searfoss, G., Ruta, M., Burgess, W. H., Jaye, M., & Schlessinger, J. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07454.x · Cited by 622
Human basic fibroblast growth factor: nucleotide sequence and genomic organization.
Abraham, J. A., Whang, J. L., Tumolo, A., Mergia, A., Friedman, J., Gospodarowicz, D., & Fiddes, J. C. (1986) · The EMBO Journal · doi:10.1002/j.1460-2075.1986.tb04530.x · Cited by 595
FGFR-4, a novel acidic fibroblast growth factor receptor with a distinct expression pattern.
Partanen, J., Mäkelä, T. P., Eerola, E., Korhonen, J., Hirvonen, H., Claesson-Welsh, L., & Alitalo, K. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb07654.x · Cited by 533
Reid, R. P., DeVita, V. T., Hellman, S., & Rosenberg, S. A. (1992) · Histopathology · doi:10.1111/j.1365-2559.1992.tb00973.x · Cited by 473
Integrin alpha v beta 3 rescues melanoma cells from apoptosis in three-dimensional dermal collagen.
Montgomery, A. M., Reisfeld, R. A., & Cheresh, D. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.19.8856 · Cited by 448
Singh, R. K., Gutman, M., Bucana, C. D., Sanchez, R., Llansa, N., & Fidler, I. J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.10.4562 · Cited by 440
Parums, D. V., Cordell, J. L., Micklem, K., Heryet, A. R., Gatter, K. C., & Mason, D. Y. (1990) · Journal of Clinical Pathology · doi:10.1136/jcp.43.9.752 · Cited by 417
Isolation of an additional member of the fibroblast growth factor receptor family, FGFR-3.
Keegan, K., Johnson, D. E., Williams, L. T., & Hayman, M. J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.4.1095 · Cited by 411
Johnson, D. E., Lu, J., Chen, H., Werner, S., & Williams, L. T. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.9.4627 · Cited by 404
Diverse forms of a receptor for acidic and basic fibroblast growth factors.
Johnson, D. E., Lee, P. L., Lu, J., & Williams, L. T. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.9.4728 · Cited by 359
Antiangiogenic therapy of transgenic mice impairs de novo tumor growth.
Parangi, S., O'Reilly, M., Christofori, G., Holmgren, L., Grosfeld, J., Folkman, J., & Hanahan, D. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.5.2002 · Cited by 344
Becker, D., Meier, C. B., & Herlyn, M. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb08543.x · Cited by 263
Self-citationFactor VIII related antigen as an endothelial cell marker in benign and malignant diseases
Sehested, M., & Hou-Jensen, K. (1981) · Virchows Archiv A Pathological Anatomy and Histology · doi:10.1007/bf00437598 · Cited by 258
Werner, S., Weinberg, W., Liao, X., Peters, K. G., Blessing, M., Yuspa, S. H., Weiner, R. L., & Williams, L. T. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05924.x · Cited by 238
Biology of tumor progression in human melanocytes.
Herlyn, M., Clark, W. H., Rodeck, U., Mancianti, M., Jambrosic, J., & Koprowski, H. (1987) · PubMed · Cited by 236
Scott, O. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.250 · Cited by 186
Constitutive Expression of Multiple Growth Factor Genes by Melanoma Cells but Not Normal Melanocytes
Rodeck, U., Melber, K., Kath, R., Menssen, H.-D., Varello, M., Atkinson, B., & Herlyn, M. (1991) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12477822 · Cited by 171
Maihle, N. J. (1996) · Mayo Clinic Proceedings · doi:10.4065/71.2.214 · Cited by 135
Regulatory factors that determine growth and phenotype of normal human melanocytes*1
Herlyn, M. (1988) · Experimental Cell Research · doi:10.1016/0014-4827(88)90271-6 · Cited by 97
Elder, D. E., Clark, W. H., Elenitsas, R., Guerry, D., & Halpern, A. C. (1993) · PubMed · Cited by 79
Walgenbach, K. J., Gratas, C., Shestak, K. C., & Becker, D. (1995) · Nature Medicine · doi:10.1038/nm0595-453 · Cited by 55
Self-citationClinical applications of monoclonal antibodies
McMichael, A. J., & Bastin, J. M. (1980) · Immunology Today · doi:10.1016/0167-5699(80)90021-3 · Cited by 32
Cited by
Fibroblast growth factor signalling: from development to cancer
Turner, N., & Grose, R. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2780 · Cited by 2,693
The FGF family: biology, pathophysiology and therapy
Beenken, A., & Mohammadi, M. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2792 · Cited by 1,945
VEGF and the quest for tumour angiogenesis factors
Ferrara, N. (2002) · Nature Reviews Cancer · doi:10.1038/nrc909 · Cited by 1,536
Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis
Presta, M., Dell’Era, P., Mitola, S., Moroni, E., Ronca, R., & Rusnati, M. (2005) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.01.004 · Cited by 1,261
FGF/FGFR signaling in health and disease
Xie, Y., Su, N., Yang, J., Tan, Q., Huang, S., Jin, M., Ni, Z., Zhang, B., Zhang, D., Luo, F., et al. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00222-7 · Cited by 904
Metadata
- Authors
- Wang, Y., & Becker, D.
- Venue
- Nature Medicine
- Published
- 1997-08
- Volume
- 3
- Issue
- 8
- Pages
- 887-893
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W1985737377
- Cited by
- 284
- References
- 30
- FWCI
- 6.30
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.